FIELD: chemistry.
SUBSTANCE: invention relates to a salt of succinate 2-((4-(1-methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)quinoline. A novel salt of 2-((4-(1-methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)quinoline is obtained and described, which can be used in treating central nervous system disorders.
EFFECT: high efficiency of using the compounds.
7 cl, 1 ex, 1 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
INHIBITORS OF PHOSPHODIESTERASE 10 ENZYME | 2013 |
|
RU2667058C2 |
(3-ARYLSULPHONYL QUINOLIN-8-YL-DIALKYL-AMINES - SELECTIVE SEROTONIN 5-HT RECEPTOR ANTAGONISTS, METHODS FOR PRODUCTION AND USE THEREOF | 2012 |
|
RU2500672C1 |
COMBINATIONS COMPRISING PDE 2 INHIBITORS SUCH AS 1-ARYL-4-METHYL- [1,2,4]TRIAZOLO[4,3-A]QUINOXALINE COMPOUNDS AND PDE 10 INHIBITORS FOR USE IN TREATMENT OF NEUROLOGICAL OR METABOLIC DISORDERS | 2013 |
|
RU2657540C2 |
COMPOUNDS, ENHANCING GLUTAMATE RECEPTOR, AND THEIR APPLICATION IN MEDICINE | 2005 |
|
RU2403242C2 |
CITRIC SALT OF INDOLE DERIVATIVE, METHOD FOR PRODUCING THEREOF, ADMINISTERING THEREOF AND BASED PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2415137C2 |
THERAPEUTIC APPLICATION OF SELECTIVE INHIBITORS PDE10 | 2003 |
|
RU2303259C2 |
NEUROGENESIS MEDIATED WITH 4-ACYLAMINOPYRIDINE DERIVATIVES | 2007 |
|
RU2451512C2 |
HALOGENATED QUINAZOLINE-THF-AMINES AS PDE1 INHIBITORS | 2015 |
|
RU2692808C2 |
SALTS OF 1-(4-(2-((1-(3,4-DIFLUOROPHENYL)-1N-PYRAZOL-3-YL)METHOXY)ETHYL)PIPERAZIN-1-YL)ETHANONE | 2016 |
|
RU2727974C2 |
IMIDAZO[1,2-a]PYRIDINE DERIVATIVES AND THEIR APPLICATION AS POSITIVE ALLOSTERIC MODULATORS OF mGluR2 RECEPTORS | 2008 |
|
RU2492170C2 |
Authors
Dates
2011-10-10—Published
2007-12-03—Filed